Stay updated on IMMUTACE Clinical Trial
Sign up to get notified when there's something new on the IMMUTACE Clinical Trial page.

Latest updates to the IMMUTACE Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe IMMUTACE clinical-trial record is displayed with its study details, including treatment, eligibility criteria, outcomes, locations, and record dates, replacing the previous access-denied screen.SummaryDifference55%

- Check20 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces updates to NIH websites and says that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check34 days agoChange DetectedThe error page footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the planned study content with an error screen. The surrounding site chrome (header/footer) remains visible, but the detailed trial information on this page is not accessible.SummaryDifference20%

Stay in the know with updates to IMMUTACE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMMUTACE Clinical Trial page.